These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12394164)

  • 1. Proper usage of pancreatic enzymes.
    Schibli S; Durie PR; Tullis ED
    Curr Opin Pulm Med; 2002 Nov; 8(6):542-6. PubMed ID: 12394164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing colonopathy in cystic fibrosis.
    Smyth RL
    Arch Dis Child; 1996 May; 74(5):464-8. PubMed ID: 8669970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic enzymes and Fibrosing Colonopathy.
    Dodge JA
    J Cyst Fibros; 2015 Jan; 14(1):153. PubMed ID: 25242743
    [No Abstract]   [Full Text] [Related]  

  • 4. Cystic fibrosis colonopathy.
    Lloyd-Still JD; Beno DW; Kimura RM
    Curr Gastroenterol Rep; 1999 Jun; 1(3):231-7. PubMed ID: 10980955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic enzymes and fibrosing colonopathy.
    Connett GJ; Rolles CJ
    Lancet; 1999 Jul; 354(9174):249-50; author reply 251. PubMed ID: 10421322
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report: colonic stricture and fibrosis associated with high-strength pancreatic enzymes in a child with cystic fibrosis.
    McHugh K; Thomson A; Tam P
    Br J Radiol; 1994 Sep; 67(801):900-1. PubMed ID: 7953234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements.
    Häusler M; Heimann G; Meilcke R; Biesterfeld S
    Gut; 2000 Oct; 47(4):598. PubMed ID: 11203308
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
    Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL
    Pediatr Dev Pathol; 1998; 1(1):74-8. PubMed ID: 10463274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.
    Littlewood JM; Connett GJ; Sander-Struckmeier S; Henniges F;
    Expert Opin Drug Saf; 2011 Mar; 10(2):197-203. PubMed ID: 21342076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic increase in intracranial pressure following pancreatic enzyme replacement therapy for cystic fibrosis.
    Nasr SZ; Schaffert D
    Pediatr Pulmonol; 1995 Jun; 19(6):396-7. PubMed ID: 7567222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
    Ramsden WH; Moya EF; Littlewood JM
    Arch Dis Child; 1998 Oct; 79(4):339-43. PubMed ID: 9875045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosing colonopathy revealing cystic fibrosis in a neonate before any pancreatic enzyme supplementation.
    Serban DE; Florescu P; Miu N
    J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):356-9. PubMed ID: 12352527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing colonopathy in a child on low-dose pancreatin.
    Taylor CJ; Steiner GM
    Lancet; 1995 Oct; 346(8982):1106-7. PubMed ID: 7564819
    [No Abstract]   [Full Text] [Related]  

  • 17. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.
    Connett GJ; Lucas JS; Atchley JT; Fairhurst JJ; Rolles CJ
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):181-3. PubMed ID: 10102230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M; Hochhaus G; Stecenko A; Bowser E; Hendeles L
    J Clin Pharmacol; 1994 Feb; 34(2):158-66. PubMed ID: 8163716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic toxicity from pancreatins: a contemporary safety issue.
    Powell CJ
    Lancet; 1999 Mar; 353(9156):911-5. PubMed ID: 10093998
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.